The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances (Q64104607)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31114366 AND SRC:MED&resulttype=core&format=json

27 April 2020

title

The beneficial effects of metformin on cancer prevention and therapy: a comprehensive review of recent advances (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31114366 AND SRC:MED&resulttype=core&format=json

27 April 2020

0 references

0 references

Nasroallah Moradi kor

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31114366 AND SRC:MED&resulttype=core&format=json

27 April 2020

author name string

Pouya Saraei

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31114366 AND SRC:MED&resulttype=core&format=json

27 April 2020

Ilia Asadi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31114366 AND SRC:MED&resulttype=core&format=json

27 April 2020

Muhammad Azam Kakar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31114366 AND SRC:MED&resulttype=core&format=json

27 April 2020

language of work or name

English

0 references

publication date

17 April 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31114366 AND SRC:MED&resulttype=core&format=json

Cancer Management and Research

27 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31114366 AND SRC:MED&resulttype=core&format=json

27 April 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31114366 AND SRC:MED&resulttype=core&format=json

27 April 2020

page(s)

3295-3313

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31114366 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial 3.0 Unported

27 April 2020

copyright license

start time

1 April 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Insulin rapidly decreases insulin-like growth factor-binding protein-1 gene transcription in streptozotocin-diabetic rats

1 reference

12 December 2020

Site-specific uncoupling and inhibition of oxidative phosphorylation by biguanides. II

1 reference

12 December 2020

Oral hypoglycaemic agents. An update

1 reference

12 December 2020

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I.

1 reference

12 December 2020

The Hallmarks of Cancer

1 reference

12 December 2020

Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain

1 reference

12 December 2020

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome

1 reference

12 December 2020

Mechanism by which metformin reduces glucose production in type 2 diabetes

1 reference

12 December 2020

Role of AMP-activated protein kinase in mechanism of metformin action

1 reference

12 December 2020

Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3).

1 reference

12 December 2020

Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study

1 reference

12 December 2020

Circulatory and respiratory reflexes caused by aromatic guanidines

1 reference

12 December 2020

Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics

1 reference

12 December 2020

Metformin and reduced risk of cancer in diabetic patients

1 reference

12 December 2020

Effect of metformin on life span and on the development of spontaneous mammary tumors in HER-2/neu transgenic mice

1 reference

12 December 2020

The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin

1 reference

12 December 2020

Metformin increases insulin sensitivity and plasma beta-endorphin in human subjects

1 reference

12 December 2020

Treating the metabolic syndrome.

1 reference

12 December 2020

Effects of tetraalkylammonium compounds with different affinities for organic cation transporters on the pharmacokinetics of metformin

1 reference

12 December 2020

Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells

1 reference

12 December 2020

Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice

1 reference

12 December 2020

AMPK phosphorylation of raptor mediates a metabolic checkpoint

1 reference

12 December 2020

Metformin versus insulin for the treatment of gestational diabetes

1 reference

12 December 2020

Biguanide-induced mitochondrial dysfunction yields increased lactate production and cytotoxicity of aerobically-poised HepG2 cells and human hepatocytes in vitro

1 reference

12 December 2020

Sulphonylureas and cancer: a case-control study

1 reference

12 December 2020

The effects of adiponectin and metformin on prostate and colon neoplasia involve activation of AMP-activated protein kinase

1 reference

12 December 2020

Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

1 reference

12 December 2020

Antidiabetic therapies affect risk of pancreatic cancer

1 reference

12 December 2020

Chemical Genomics Identifies the Unfolded Protein Response as a Target for Selective Cancer Cell Killing during Glucose Deprivation

1 reference

12 December 2020

Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer

1 reference

12 December 2020

New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes

1 reference

12 December 2020

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

1 reference

12 December 2020

AMPK in Health and Disease

1 reference

12 December 2020

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission

1 reference

12 December 2020

Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16

1 reference

12 December 2020

Long-term metformin use is associated with decreased risk of breast cancer.

1 reference

12 December 2020

Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure.

1 reference

12 December 2020

Metformin, independent of AMPK, inhibits mTORC1 in a rag GTPase-dependent manner

1 reference

12 December 2020

More favorable progesterone receptor phenotype of breast cancer in diabetics treated with metformin

1 reference

12 December 2020

Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardiovascular Outcomes and Regulation of Glycaemia in Diabetes) clinical t

1 reference

12 December 2020

Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state

1 reference

12 December 2020

Metformin in type 1 diabetes reduces insulin requirements without significantly improving glycaemic control

1 reference

12 December 2020

Metformin Suppresses Colorectal Aberrant Crypt Foci in a Short-term Clinical Trial

1 reference

12 December 2020

Metformin in polycystic ovary syndrome

1 reference

12 December 2020

Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status

1 reference

12 December 2020

Metformin and cancer risk in diabetic patients: a systematic review and meta-analysis.

1 reference

12 December 2020

Metformin and cancer occurrence in insulin-treated type 2 diabetic patients

1 reference

12 December 2020

Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort

1 reference

12 December 2020

Type 2 diabetes increases and metformin reduces total, colorectal, liver and pancreatic cancer incidences in Taiwanese: a representative population prospective cohort study of 800,000 individuals

1 reference

12 December 2020

Metformin and cancer: new applications for an old drug

1 reference

12 December 2020

Hallmarks of Cancer: The Next Generation

1 reference

12 December 2020

Metformin Decreases the Dose of Chemotherapy for Prolonging Tumor Remission in Mouse Xenografts Involving Multiple Cancer Cell Types

1 reference

12 December 2020

Investigation of the potential effects of metformin on atherothrombotic risk factors in hyperlipidemic rats

1 reference

12 December 2020

Understanding the benefit of metformin use in cancer treatment

1 reference

12 December 2020

Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.

1 reference

12 December 2020

Lower risk of cancer in patients on metformin in comparison with those on sulfonylurea derivatives: results from a large population-based follow-up study

1 reference

12 December 2020

Cellular and molecular mechanisms of metformin: an overview

1 reference

12 December 2020

Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue

1 reference

12 December 2020

The role of metformin in the management of NAFLD

1 reference

12 December 2020

Metformin: multi-faceted protection against cancer

1 reference

12 December 2020

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer

1 reference

12 December 2020

Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis

1 reference

12 December 2020

Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells

1 reference

12 December 2020

Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study.

1 reference

12 December 2020

Cancer risk associated with use of metformin and sulfonylurea in type 2 diabetes: a meta-analysis

1 reference

12 December 2020

Metformin use and improved response to therapy in esophageal adenocarcinoma

1 reference

12 December 2020

Metformin and prostate cancer: reduced development of castration-resistant disease and prostate cancer mortality

1 reference

12 December 2020

Mitochondrial energetic and AKT status mediate metabolic effects and apoptosis of metformin in human leukemic cells.

1 reference

12 December 2020

Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK.

1 reference

12 December 2020

A Cohort Study of Metformin Exposure and Survival in Patients with Stage I-III Colorectal Cancer

1 reference

12 December 2020

Contributions of AMPK and p53 dependent signaling to radiation response in the presence of metformin

1 reference

12 December 2020

Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes

1 reference

12 December 2020

Association of diabetes mellitus and metformin use with biochemical recurrence in patients treated with radical prostatectomy for prostate cancer

1 reference

12 December 2020

Reprogramming metabolism with metformin improves tumor oxygenation and radiotherapy response

1 reference

12 December 2020

Risk of cancer in diabetes: the effect of metformin

1 reference

12 December 2020

Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway

1 reference

12 December 2020

Low and high linear energy transfer radiation sensitization of HCC cells by metformin

1 reference

12 December 2020

An update on the pharmacogenomics of metformin: progress, problems and potential

1 reference

12 December 2020

Use of metformin in diseases of aging

1 reference

12 December 2020

Metformin inhibits mitochondrial complex I of cancer cells to reduce tumorigenesis

1 reference

12 December 2020

Metformin sensitizes prostate cancer cells to radiation through EGFR/p-DNA-PKCS in vitro and in vivo.

1 reference

12 December 2020

Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase

1 reference

12 December 2020

A pilot 'window of opportunity' neoadjuvant study of metformin in localised prostate cancer.

1 reference

12 December 2020

Metformin and cancer: mounting evidence against an association.

1 reference

12 December 2020

Metformin plus sorafenib highly impacts temozolomide resistant glioblastoma stem-like cells

1 reference

12 December 2020

Dichloroacetate enhances apoptotic cell death via oxidative damage and attenuates lactate production in metformin-treated breast cancer cells

1 reference

12 December 2020

Metformin in cancer prevention and therapy

1 reference

12 December 2020

Involvement of metformin and AMPK in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy

1 reference

12 December 2020

Metformin: from mechanisms of action to therapies

1 reference

12 December 2020

Effects of metformin on head and neck cancer: a systematic review

1 reference

12 December 2020

Biological response of cancer cells to radiation treatment

1 reference

12 December 2020

Metformin for chemoprevention of metachronous colorectal adenoma or polyps in post-polypectomy patients without diabetes: a multicentre double-blind, placebo-controlled, randomised phase 3 trial.

1 reference

12 December 2020

Metformin enhances the response to radiotherapy in diabetic patients with rectal cancer.

1 reference

12 December 2020

Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis

1 reference

12 December 2020

AMPK signalling in health and disease.

1 reference

12 December 2020

Metformin and improved treatment outcomes in radiation therapy - A review

1 reference

12 December 2020

Metformin and Prostate Cancer: a New Role for an Old Drug.

1 reference

12 December 2020

Metformin: historical overview

1 reference

12 December 2020

Identifiers

DOI

10.2147/CMAR.S200059

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31114366 AND SRC:MED&resulttype=core&format=json

27 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31114366 AND SRC:MED&resulttype=core&format=json

27 April 2020

PubMed publication ID

31114366

1 reference